A stochastic framework for evaluating CAR T cell therapy efficacy and variability

DOI10.1016/J.MBS.2024.109141MaRDI QIDQ6539718zbMATH OpenFDO

Authors Chau Hoang, Tuan Anh Phan, Cameron J. Turtle, Jianjun Paul Tian

Publication date 15 May 2024

Published in Mathematical Biosciences (Search for Journal in Brave)

zbMATH Keywords

stopping timestochastic modelingergodic distributionCAR-T cell therapy

Mathematics Subject Classification ID

Medical applications (general) (92C50) Applications of stochastic analysis (to PDEs, etc.) (60H30)

Recommendations

• Parameter estimation and treatment optimization in a stochastic model for immunotherapy of cancer
• Modeling CAR T-cell therapy with patient preconditioning
• A stochastic model for the growth of cancer tumors
• Basic stochastic model for tumor virotherapy
• Numerical simulation of a stochastic model for cancerous cells submitted to chemotherapy

Cites work

• scientific article; zbMATH DE number 43057 (Why is no real title available?)
• scientific article; zbMATH DE number 1099342 (Why is no real title available?)
• Basic stochastic model for tumor virotherapy
• Data-driven analysis of a mechanistic model of CAR T cell signaling predicts effects of cell-to-cell heterogeneity
• Deterministic and stochastic modeling for PDGF-driven gliomas reveals a classification of gliomas
• Dynamics of cholera epidemic models in fluctuating environments
• Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
• Stochastic modeling of tumor progression and immune evasion

Cited in

(1)

• Mathematical model for IL-2-based cancer immunotherapy

This page was built for publication: A stochastic framework for evaluating CAR T cell therapy efficacy and variability

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6539718)